ABVC BioPharma, Inc. Common Stock

ABVC XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

33M

Short interest (May 15)

1.1%

Net Short (Jun 03 ): -0.1%

Borrow Fee

4.63%

↑ 4.4%

Available Shares

60K

↓ 25.9%

Price Chart

Company Overview

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001173313

Asset Type: CS

Market Data

Market Cap: $32,500,552

Employees: 19

Status: Active

Short Interest

Current Borrow Fee 4.63%

Range: 4.23% - 4.63%

Available Shares 60K

Range: 25K - 75K

Recent Changes

Fee Change: ↑ 3.6%

Available Change: ↓ 6.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime